-- Do not use androgen therapy if:
- You are a man with known or suspected prostate cancer, or if you have breast cancer.
- You are a woman who is breastfeeding, pregnant, or may become pregnant.
-- Patients treated with androgens may be at an increased risk for prostate cancer. Your doctor will likely monitor for prostate cancer before and during treatment with androgens.
-- Patients with benign prostatic hypertrophy (BPH) who are treated with androgens are at an increased risk of worsening of BPH symptoms.
About Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc., of Marietta, Georgia, is the U.S. subsidiary of Solvay Pharmaceuticals. For more information, visit www.solvaypharmaceuticals-us.com.
Solvay Pharmaceuticals is a research driven group of companies that constitute the global pharmaceutical business of the Solvay Group. These companies seek to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines, gastroenterology, and men's and women's health. Its 2007 sales were EUR 2.6 billion and it employs more than 9,000 people worldwide. For more information, visit www.solvaypharmaceuticals.com.
Solvay is an international chemical and pharmaceutical Group with
headquarters in Brussels. It employs more than 28,000 people in 50 countries.
In 2007, its consolidated sales amounted to EUR 9.6 billion, generated by its
|SOURCE Solvay Pharmaceuticals, Inc.|
Copyright©2009 PR Newswire.
All rights reserved